{"id":"https://openalex.org/W2108718878","doi":"https://doi.org/10.1111/j.1365-2265.1993.tb02379.x","title":"Pharmacokinetic properties of the tocolytic agent [Mpa1 d \u2010Tyr(Et)2, Thr4, Orn8]\u2010oxytocin (antocin) in healthy volunteers","display_name":"Pharmacokinetic properties of the tocolytic agent [Mpa1 d \u2010Tyr(Et)2, Thr4, Orn8]\u2010oxytocin (antocin) in healthy volunteers","publication_year":1993,"publication_date":"1993-09-01","ids":{"openalex":"https://openalex.org/W2108718878","doi":"https://doi.org/10.1111/j.1365-2265.1993.tb02379.x","mag":"2108718878","pmid":"https://pubmed.ncbi.nlm.nih.gov/8222299"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2265.1993.tb02379.x","doi":"https://doi.org/10.1111/j.1365-2265.1993.tb02379.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2265.1993.tb02379.x","pdf_url":null,"source":{"id":"https://openalex.org/S182143151","display_name":"Clinical Endocrinology","issn_l":"0300-0664","issn":["0300-0664","1365-2265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Endocrinology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"S. Lundin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137844","display_name":"Sk\u00e5ne University Hospital","ror":"https://ror.org/02z31g829","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210137844"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"S. Lundin","raw_affiliation_strings":["Department of Clinical Pharmacology, Lund University Hospital, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Lund University Hospital, Sweden","institution_ids":["https://openalex.org/I4210137844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110047377","display_name":"A. Broeders","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Broeders","raw_affiliation_strings":["Ferring Research Institute, S-200 62 Malmo\u0308, Sweden","Ferring Research Institute, S-200 62 Malm\u00f6, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ferring Research Institute, S-200 62 Malmo\u0308, Sweden","institution_ids":[]},{"raw_affiliation_string":"Ferring Research Institute, S-200 62 Malm\u00f6, Sweden","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068991478","display_name":"Per Melin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Melin","raw_affiliation_strings":["Ferring Research Institute, S-200 62 Malmo\u0308, Sweden","Ferring Research Institute, S-200 62 Malm\u00f6, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ferring Research Institute, S-200 62 Malmo\u0308, Sweden","institution_ids":[]},{"raw_affiliation_string":"Ferring Research Institute, S-200 62 Malm\u00f6, Sweden","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210137844"],"apc_list":{"value":4250,"currency":"USD","value_usd":4250},"apc_paid":null,"fwci":0.6609,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.61675227,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"39","issue":"3","first_page":"369","last_page":"374"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11541","display_name":"Neuroendocrine regulation and behavior","score":0.4643999934196472,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11541","display_name":"Neuroendocrine regulation and behavior","score":0.4643999934196472,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.1826000064611435,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14486","display_name":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","score":0.035599999129772186,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oxytocin-antagonist","display_name":"oxytocin antagonist","score":0.8880000114440918},{"id":"https://openalex.org/keywords/tocolytics","display_name":"tocolytic agents","score":0.8949999809265137},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9869999885559082},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.8939999938011169},{"id":"https://openalex.org/keywords/red-blood-cell-binding","display_name":"red blood cell binding","score":0.8989999890327454},{"id":"https://openalex.org/keywords/plasma-clearance","display_name":"plasma clearance","score":0.8550000190734863},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.9470000267028809},{"id":"https://openalex.org/keywords/biological-half-life","display_name":"biological half-life","score":0.9330000281333923},{"id":"https://openalex.org/keywords/desmopressin","display_name":"desmopressin","score":0.8180000185966492},{"id":"https://openalex.org/keywords/vasopressin","display_name":"vasopressin","score":0.8019999861717224},{"id":"https://openalex.org/keywords/biphasic-elimination","display_name":"biphasic elimination","score":0.5529999732971191}],"concepts":[{"id":"https://openalex.org/C2778702241","wikidata":"https://www.wikidata.org/wiki/Q241006","display_name":"Desmopressin","level":2,"score":0.8056414127349854},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7131125330924988},{"id":"https://openalex.org/C176685330","wikidata":"https://www.wikidata.org/wiki/Q857638","display_name":"Radioimmunoassay","level":2,"score":0.6879713535308838},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6785891056060791},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6389375925064087},{"id":"https://openalex.org/C2776176026","wikidata":"https://www.wikidata.org/wiki/Q169960","display_name":"Oxytocin","level":2,"score":0.6120062470436096},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5963339805603027},{"id":"https://openalex.org/C2776370428","wikidata":"https://www.wikidata.org/wiki/Q21124841","display_name":"Vasopressin","level":2,"score":0.5864631533622742},{"id":"https://openalex.org/C2988731192","wikidata":"https://www.wikidata.org/wiki/Q7410159","display_name":"Blood sampling","level":2,"score":0.44690391421318054},{"id":"https://openalex.org/C56191518","wikidata":"https://www.wikidata.org/wiki/Q416997","display_name":"Peptide hormone","level":3,"score":0.43727993965148926},{"id":"https://openalex.org/C2776575606","wikidata":"https://www.wikidata.org/wiki/Q79749","display_name":"Blood plasma","level":2,"score":0.4310375154018402},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2954829931259155},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.2553044855594635}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001127","descriptor_name":"Arginine Vasopressin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001798","descriptor_name":"Blood Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004912","descriptor_name":"Erythrocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007457","descriptor_name":"Iodine Radioisotopes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014667","descriptor_name":"Vasopressins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014668","descriptor_name":"Vasotocin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014668","descriptor_name":"Vasotocin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014668","descriptor_name":"Vasotocin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D015149","descriptor_name":"Tocolytic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2265.1993.tb02379.x","doi":"https://doi.org/10.1111/j.1365-2265.1993.tb02379.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2265.1993.tb02379.x","pdf_url":null,"source":{"id":"https://openalex.org/S182143151","display_name":"Clinical Endocrinology","issn_l":"0300-0664","issn":["0300-0664","1365-2265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Endocrinology","raw_type":"journal-article"},{"id":"pmid:8222299","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8222299","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical endocrinology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W109684818","https://openalex.org/W1601603974","https://openalex.org/W1865641728","https://openalex.org/W1893651774","https://openalex.org/W1899028674","https://openalex.org/W1969668906","https://openalex.org/W1977190194","https://openalex.org/W1989325575","https://openalex.org/W1991307836","https://openalex.org/W2003846771","https://openalex.org/W2026158787","https://openalex.org/W2028082499","https://openalex.org/W2029464937","https://openalex.org/W2033439047","https://openalex.org/W2037143193","https://openalex.org/W2045580207","https://openalex.org/W2046829365","https://openalex.org/W2048265318","https://openalex.org/W2065037721","https://openalex.org/W2076346384","https://openalex.org/W2078216398","https://openalex.org/W2085288958","https://openalex.org/W2091880280","https://openalex.org/W2093169206","https://openalex.org/W2119891717"],"related_works":["https://openalex.org/W1865641728","https://openalex.org/W1977190194","https://openalex.org/W2521623586","https://openalex.org/W2133987719","https://openalex.org/W2007844076","https://openalex.org/W2334758063","https://openalex.org/W2016082001","https://openalex.org/W50021174","https://openalex.org/W2730204123","https://openalex.org/W193543979"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1,92,106,156,198],"aim":[2],"of":[3,11,45,81,94,97,108,117,136,163,185,202,226],"this":[4],"study":[5,8,173],"was":[6,23,50,72,86,99,110,119,128,158,165,178],"to":[7,47,139,205,216],"the":[9,13,43,82,115,125,161,186,194,227],"pharmacokinetics":[10],"antocin,":[12],"tocolytic":[14],"oxytocin":[15,206],"antagonist":[16],"[Mpa1,":[17],"D-Tyr2(Et),":[18],"Thr4,":[19],"Orn8]-oxytocin.":[20],"DESIGN:":[21],"Antocin":[22,71],"injected":[24],"intravenously":[25],"as":[26],"a":[27,75,103,171,175],"bolus":[28],"dose":[29],"(5":[30],"mumol).":[31],"Blood":[32],"samples":[33],"were":[34],"taken":[35],"at":[36],"intervals":[37],"for":[38],"240":[39],"minutes.":[40,132],"In":[41],"addition,":[42],"binding":[44,85,215],"125I-Tyr10-antocin":[46,137],"blood":[48,145,188,217],"constituents":[49,218],"determined":[51],"and":[52,56,67,124,143,152,160,207],"compared":[53,204],"with":[54],"125I-AVP":[55],"125I-[Mpa1,":[57],"D-Arg8]-vasopressin":[58],"(desmopressin).":[59],"SUBJECTS:":[60],"Eight":[61],"healthy,":[62],"non-smoking":[63],"adults,":[64],"three":[65],"male":[66],"five":[68],"female.":[69],"MEASUREMENTS:":[70],"measured":[73],"using":[74,88],"specific":[76],"radioimmunoassay":[77],"after":[78],"prior":[79],"extraction":[80],"plasma.":[83],"Plasma":[84],"estimated":[87],"polyethyleneglycol":[89],"precipitation.":[90],"RESULTS:":[91],"rate":[93],"plasma":[95,140,200],"disappearance":[96],"antocin":[98,109,164,203],"best":[100],"fitted":[101],"by":[102,212,221],"biexponential":[104],"curve.":[105],"clearance":[107,162,201],"23.5":[111],"+/-":[112,121,130],"7.6":[113],"l/h,":[114],"volume":[116],"distribution":[118],"13.1":[120],"3.8":[122],"l":[123],"biological":[126],"half-life":[127,157],"39.0":[129],"4.1":[131],"A":[133],"greater":[134],"proportion":[135],"bound":[138],"proteins":[141],"(33.5%)":[142],"red":[144],"cells":[146],"(13%)":[147],"than":[148,167,220],"did":[149],"125I-AVP,":[150],"125I-desmopressin":[151],"unlabelled":[153],"desmopressin.":[154],"CONCLUSIONS:":[155],"longer":[159],"less":[166],"that":[168],"found":[169],"in":[170,223],"previous":[172],"when":[174],"non-specific":[176],"antiserum":[177],"used.":[179],"This":[180],"is":[181],"most":[182],"likely":[183],"because":[184],"extended":[187],"sampling":[189],"time":[190],"period":[191],"which":[192],"revealed":[193],"biphasic":[195],"decay":[196],"pattern.":[197],"higher":[199],"desmopressin":[208],"may":[209],"be":[210],"explained":[211],"its":[213],"increased":[214],"rather":[219],"differences":[222],"enzymatic":[224],"degradation":[225],"molecules.":[228]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}